22 patients enrolled in study 201 and a total of 21 patients ... a clear blueprint of how to market and commercialize ultra rare drugs based on approved drugs for other MPS diseases, which are listed ...

Nexad, a new adtech startup building a network for AI-native advertising, secured a seed investment round.